Microbial translocation is a cause of systemic immune activation in chronic HIV infection
By J. Brenchley. Retrovirology, 2006
2,337 citations recorded by the source corpus.
Chronic activation of the immune system is a hallmark of progressive HIV infection and better predicts disease outcome than plasma viral load, yet its etiology remains obscure. Here we show that circulating microbial products, probably derived from the gastrointestinal tract, are a cause of HIV-related systemic immune activation. Circulating lipopolysaccharide, which we used as an indicator of microbial translocation, was significantly increased in chronically HIV-infected individuals and in simian immunodeficiency virus (SIV)-infected rhesus macaques (P r 0.002). We show that increased lipopolysaccharide is bioactive in vivo and correlates with measures of innate and adaptive immune activation. Effective antiretroviral therapy seemed to reduce microbial translocation partially. Furthermore, in nonpathogenic SIV infection of sooty mangabeys, microbial translocation did not seem to occur. These data establish a mechanism for chronic immune activation in the context of a compromised gastrointestinal mucosal surface and provide new directions for therapeutic interventions that modify the consequences of acute HIV infection. Chronic immune activation is a characteristic feature of progressive HIV disease. Indeed, polyclonal B-cell activation was one of the first described immunological abnormalities in HIV-infected individuals 1 . Subsequently, increased T-cell turnover 2 , increased frequencies of T cells with an activated phenotype 3 , and increased serum levels of proinflammatory cytokines and chemokines 4 were observed. Notably, the degree of immune activation is a better predictor of disease progression than plasma viral load 5 . However, the underlying causes of immune activation have remained elusive 6,7 .
Subfields: Immunology, Infectious Diseases, Virology
View Paper: https://www.semanticscholar.org/paper/2e313c1d629bf50efd7a5f39ee9d9f01ddb287b1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Infectious Diseases
In Virology
Citations in the corpus
- Role of the Microbiota in Immunity and inflammation (2014, background): “In a number of models of gastrointestinal infections, such as Toxoplasma gondii and Yersinia pseudotuberculosis, immunopathology can also induce the translocation of commensal bacteria (Brenchley and Douek, 2012; Brenchley et al., 2006; Estes et al., 2010; Hand et al., 2012; Heimesaat et al., 2006; ”
- Emerging Concepts in the Immunopathogenesis of AIDS (2009, background): “Recent studies have shown that chronically HIV-infected individuals have significantly increased levels of plasma LPS compared to uninfected individuals (52).”
- Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral-Treated HIV Infection (2009, neutral): “volved with HIV/SIV immunopathogenesis [8].”
- Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity Allowing Microbial Translocation (2010, background): “barrier is likely mediated via immune cell activation due to viral replication [14,25].”
- Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage Dysfunction (2017, neutral): “Microbial translocation has been shown to occur in HIV patients due to a loss of immune control at the gut mucosa, and this translocation leads to a state of immune activation and systemic inflammation that is reminiscent of what is observed in normal aging (Brenchley et al., 2006).”
- Immune activation and inflammation in HIV‐1 infection: causes and consequences (2008, background): “Interestingly, HIV-1 infection is associated with a significant increase of plasma LPS levels, an indicator of microbial translocation, which is directly correlated with measures of immune activation [42].”
- Chylomicrons promote intestinal absorption of lipopolysaccharides Published, JLR Papers in Press, September 24, 2008. (2009, background): “Increased LPS absorption, for example, could exacerbate the risk for several chronic diseases, such as alcoholic liver injury (42), nonalcoholic steatohepatitis (18), HIV/AIDS (40), and inflammatory bowel disease (43, 44).”